Pablo Corral: Are Cholesterol and Inflammation Really Equal in Atherosclerosis?
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared a post on LinkedIn about a recent article by Rui-Xiang Zeng et al., published in JACC Journals:
“Interesting to see cholesterol and inflammation portrayed as equal partners in atherosclerosis.
The problem is that the evidence is not remotely symmetrical.
For LDL-C lowering we have decades of randomized trials—4S, HPS, PROVE-IT, IMPROVE-IT, FOURIER, ODYSSEY, CLEAR Outcomes—consistently showing that lowering LDLc reduces cardiovascular events.
For anti-inflammatory therapy?
A small handful of trials, modest benefits, and sometimes meaningful safety concerns.
Inflammation matters.
No serious scientist denies that.
But putting cholesterol and inflammation on the same evidentiary level is a bit like calling a tie when one side is supported by a vast body of randomized trial evidence and the other by only limited clinical proof.
LDL isn’t just part of the story.
It’s the only target that has repeatedly proven in randomized trials that moving it changes outcomes.
Evidence first.
Symmetry later.”
Title: Cholesterol-Inflammation Fusion Hypothesis in Atherosclerosis: An Evolving Paradigm in Pathogenesis and Therapy
Authors: Rui-Xiang Zeng, Sha Li, Jian-Jun Li
Read the Full Article on JACC Journals

Other posts about Pablo Corral on Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026